Skip to content

Clinical study to evaluate the safety and efficacy assessment of Hylexxa Deep intradermal injectable gel

Clinical study to evaluate the safety and efficacy assessment of Hylexxa Deep intradermal injectable gel for correcting nasolabial folds

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20150101020514N39
Enrollment
30
Registered
2026-01-24
Start date
2026-02-08
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasolabial folds. Changes in skin texture

Interventions

Intervention group: One treatment session with 1-2 ml of Hylexxa Deep intradermal gel inject to nasolabial lines. Hylexxa Deep is a syringe containing hyaluronic acid ready for injection, sterile, no

Sponsors

Mavar salamat yas company
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 18-65 year old men and women Moderate to severe nasolabial folds based on Allergan criteria The opportunity to accompany the visit programs and study process Signing the informed consent form and agree to a 6-month follow-up

Exclusion criteria

Exclusion criteria: Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment. Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry Planning to undergo any of these procedures at any time during the study Auto immune or immune deficiency diseases Allergy to gram positive bacteria protein, gel ingredients Pregnancy and Lactation

Design outcomes

Primary

MeasureTime frame
Severity of nasolabial folds. Timepoint: Before intervention and 2 weeks later. Method of measurement: 5 scale Allergan photo numeric grading.

Secondary

MeasureTime frame
Depth, area and volume of nasolabial fold. Timepoint: Before intervention and 2, 12 and 24 weeks later. Method of measurement: Visioface camera.;Thickness and density of dermis. Timepoint: Before intervention and 2 and 24 weeks later. Method of measurement: Skin ultrasound.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAniseh Samadi

Tehran University of Medical Sciences

aniseh_samadi@yahoo.com+98 21 8896 0880

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 7, 2026